Bi-functional antibody-CRISPR/Cas12a ribonucleoprotein conjugate for improved immunoassay performance
Analytica Chimica Acta · 2023
DOI: 10.1016/j.aca.2023.341211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2023. Verfasst von Fei Deng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Biomedical Engineering, University of New South Wales, Sydney, 2052, Australia; ARC Centre of Excellence in Nanoscale Biophotonics…. Hauptthemen laut MEDLINE: Biosensing Techniques, Cryptosporidiosis, Cryptosporidium, Immunoconjugates. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Australian Research Council, ARC Centre for Nanoscale BioPhotonics.
Abstract (Originalsprache)
Protein conjugates are commonly used in biochemistry, including diagnostic platforms such as antibody-based immunoassays. Antibodies can be bound to a variety of molecules creating conjugates with desirable functions, particularly for imaging and signal amplification. Cas12a is a recently discovered programable nuclease with the remarkable capability to amplify assay signals due to its trans-cleavage property. In this study, we directly conjugated antibody with Cas12a/gRNA ribonucleoprotein without the loss of function in either constituent. The conjugated antibody was suitable for immunoassays and the conjugated Cas12a was capable of amplifying the signal produced in an immunosensor without the need to change the original assay protocol. We applied the bi-functional antibody-Cas12a/gRNA conjugate to successfully detect two different types of targets, a whole pathogenic microorganism, Cryptosporidium, and a small protein, cytokine IFN-γ, with sensitivity reaching one single microorganism per sample and 10 fg/mL for IFN-γ, respectively. With simple substitution of the antibody conjugated with the Cas12a/gRNA RNP, this approach can potentially be applied to increase sensitivity of a variety of immunoassays for a broad range of different analytes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Biomedical Engineering, University of New South Wales, Sydney, 2052, Australia; ARC Centre of Excellence in Nanoscale Biophotonics, University of New South Wales, Sydney, 2052, Australia. Electronic a…
- Graduate School of Biomedical Engineering, University of New South Wales, Sydney, 2052, Australia.
- Graduate School of Biomedical Engineering, University of New South Wales, Sydney, 2052, Australia; ARC Centre of Excellence in Nanoscale Biophotonics, University of New South Wales, Sydney, 2052, Australia.
Förderung
- Australian Research Council
- ARC Centre for Nanoscale BioPhotonics
Zitieren
APA
Deng, F., Li, Y., Hall, T., Vesey, G., & Goldys, E. M. (2023). Bi-functional antibody-CRISPR/Cas12a ribonucleoprotein conjugate for improved immunoassay performance. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2023.341211
Vancouver
Deng F, Li Y, Hall T, Vesey G, Goldys EM. Bi-functional antibody-CRISPR/Cas12a ribonucleoprotein conjugate for improved immunoassay performance. Analytica Chimica Acta. 2023. doi:10.1016/j.aca.2023.341211
BibTeX
@article{Deng2023,
author = {Deng, Fei and Li, Yi and Hall, Tim and Vesey, Graham and Goldys, Ewa M},
title = {Bi-functional antibody-CRISPR/Cas12a ribonucleoprotein conjugate for improved immunoassay performance},
journal = {Analytica Chimica Acta},
year = {2023},
doi = {10.1016/j.aca.2023.341211}
}
EUVIMED